|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 707601-707625 of 2347236 (93890 Page(s) Totally)
<< < 28300 28301 28302 28303 28304 28305 28306 28307 28308 28309 > >>
View [10|25|50] records per page
| 淡江大學 |
2014-05-30 |
Randomized graph states and their entanglement properties
|
Wu, Jun-Yi;Rossi, Matteo;Kampermann, Hermann;Severini, Simone;Kwek, Leong Chuan;Macchiavello, Chiara;Bruß, Dagmar |
| 臺大學術典藏 |
2021-12-16T06:13:11Z |
Randomized multi-reader evaluation of automated detection and segmentation of brain tumors in stereotactic radiosurgery with deep neural networks
|
Lu, Shao-Lun; Xiao, Fu-Ren; Cheng, Jason Chia-Hsien; Yang, Wen-Chi; Cheng, Yueh-Hung; Chang, Yu-Cheng; Lin, Jhih-Yuan; Liang, Chih-Hung; Lu, Jen-Tang; YA-FANG CHEN; Hsu, Feng-Ming |
| 臺大學術典藏 |
2022-01-07T00:59:23Z |
Randomized multi-reader evaluation of automated detection and segmentation of brain tumors in stereotactic radiosurgery with deep neural networks
|
Lu S.-L.; Xiao F.-R.; CHIA-HSIEN CHENG; Yang W.-C.; Cheng Y.-H.; Chang Y.-C.; Lin J.-Y.; Liang C.-H.; Lu J.-T.; Chen Y.-F.; Hsu F.-M. |
| 臺大學術典藏 |
2022-04-25T06:27:57Z |
Randomized multi-reader evaluation of automated detection and segmentation of brain tumors in stereotactic radiosurgery with deep neural networks
|
SHAO-LUN LU; Xiao F.-R.; Cheng J.C.-H.; Yang W.-C.; Cheng Y.-H.; Chang Y.-C.; Lin J.-Y.; Liang C.-H.; Lu J.-T.; Chen Y.-F.; Hsu F.-M. |
| 臺大學術典藏 |
2022-04-26T07:50:30Z |
Randomized multi-reader evaluation of automated detection and segmentation of brain tumors in stereotactic radiosurgery with deep neural networks
|
Lu S.-L.; Xiao F.-R.; Cheng J.C.-H.; WEN-CHI YANG; Cheng Y.-H.; Chang Y.-C.; Lin J.-Y.; Liang C.-H.; Lu J.-T.; Chen Y.-F.; Hsu F.-M. |
| 嘉南藥理大學 |
2019 |
Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia
|
Liu, Jien-Wei; Chen, Yen-Hsu; Lee, Wen-Sen; Lin, Jung-Chung; Huang, Ching-Tai; Lin, Hsi-Hsun; Liu, Yung-Ching; Chuang, Yin-Ching; Tang, Hung-Jen; Chen, Yao-Shen; Ko, Wen-Chien; Lu, Min-Chi; Wang, Fu-Der |
| 國立成功大學 |
2019 |
Randomized noninferiority trial of cefoperazone-sulbactam versus cefepime in the treatment of hospital-acquired and healthcare-associated pneumonia
|
Liu, J.-W.;Chen, Y.-H.;Lee, W.-S.;Lin, J.-C.;Huang, C.-T.;Lin, H.-H.;Liu, Y.-C.;Chuang, Y.-C.;Tang, H.-J.;Chen, Y.-S.;Ko, W.-C.;Lu, M.-C.;Wangn, F.-D. |
| 國立臺灣大學 |
1986-08 |
Randomized Occupancy Problems and Related Waiting Time Distributions
|
葉小蓁; Yeh, Hsiaw-Chan |
| 國立臺灣大學 |
2016 |
Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9-14 Years Versus a 3-Dose Regimen in Women Aged 15-25 Years
|
Puthanakit, Thanyawee; Huang, Li-Min; Chiu, Cheng-Hsun; Tang, Ren-Bin; Schwarz, Tino F.; Esposito, Susanna; Frenette, Louise; Giaquinto, Carlo; McNeil, Shelly; Rheault, Paul; Durando, Paolo; Horn, Michael; Klar, Maximilian; Poncelet, Sylviane; De Simoni, Stephanie; Friel, Damien; De Muynck, Benoit; Suryakiran, Pemmaraju V.; Hezareh, Marjan; Descamps, Dominique; Thomas, Florence; Struyf, Frank; 黃立民 |
| 臺大學術典藏 |
2021-06-24T07:16:25Z |
Randomized open trial comparing 2-dose regimens of the human papillomavirus 16/18 as04-adjuvanted vaccine in girls aged 9-14 years versus a 3-dose regimen in women aged 15-25 years
|
Puthanakit T.; LI-MIN HUANG; Chiu C.-H.; Tang R.-B.; Schwarz T.F.; Esposito S.; Frenette L.; Giaquinto C.; McNeil S.; Rheault P.; Durando P.; Horn M.; Klar M.; Poncelet S.; De Simoni S.; Friel D.; De Muynck B.; Suryakiran P.V.; Hezareh M.; Descamps D.; Thomas F.; Struyf F. |
| 國家衛生研究院 |
2014-05 |
Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad
|
Denlinger, CS;Sym, SJ;Bendell, JC;Alsina, M;Watkins, D;Chao, Y;Cubillo, A;Kunz, PL;Sun, WJ;Baeksgaard, L;Chen, LT;Horgan, K;Frye, S;Kudia, AJ;McDonagh, CF;Czibere, AG;Moyo, VM;Chibaudel, B;Bang, YJ |
| 國立成功大學 |
2016-08 |
Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
|
Abou-Alfa, Ghassan K.;Puig, Oscar;Daniele, Bruno;Kudo, Masatoshi;Merle, Philippe;Park, Joong-Won;Ross, Paul;Peron, Jean-Marie;Ebert, Oliver;Chan, Stephen;Poon, Tung Ping;Colombo, Massimo;Okusaka, Takuji;Ryoo, Baek-Yeol;Minguez, Beatriz;Tanaka, Takayoshi;Ohtomo, Toshihiko;Ukrainskyj, Stacey;Boisserie, Frederic;Rutman, Olga;Chen, Ya-Chi;Xu, Chao;Shochat, Eliezer;Jukofsky, Lori;Reis, Bernhard;Chen, Gong;Di Laurenzio, Laura;Lee, Ray;Yen, Chia-Jui |
| 國家衛生研究院 |
2011-02 |
Randomized phase II study of PEP02, irinotecan, or docetaxel as a second-line therapy in gastric or gastroesophageal junction adenocarcinoma
|
Cunningham, D;Park, S;Kang, Y;Chao, Y;Chen, L;Rees, C;Lim, H;Tabernero, J;Yeh, G;De Gramont, A |
| 臺大學術典藏 |
2020-05-26T09:27:06Z |
Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer
|
Orlando M.;Linn C;Peng G;Blair J.M;Chen Y.-M;Xiu Q;Kang J.-H;Liang J;Chih-Hsin Yang;Ahn M.-J; Ahn M.-J; CHIH-HSIN YANG; Liang J; Kang J.-H; Xiu Q; Chen Y.-M; Blair J.M; Peng G; Linn C; Orlando M. |
| 臺大學術典藏 |
2020-05-26T09:26:44Z |
Randomized phase II trial of gefitinib with and without pemetrexed as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer with activating epidermal growth factor receptor mutations
|
Chih-Hsin Yang;Orlando M;Puri T;Enatsu S;Wang X;Kim J.-H;Kang J.H;Nakagawa K;He J;Yang P.-C;Murakami H;Cheng Y; Cheng Y; Murakami H; Yang P.-C; He J; Nakagawa K; Kang J.H; Kim J.-H; Wang X; Enatsu S; Puri T; Orlando M; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-12-02T02:33:19Z |
Randomized phase II trial of gefitinib with and without pemetrexed as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer with activating epidermal growth factor receptor mutations
|
Cheng Y.; Murakami H.; Pan-Chyr Yang; He J.; Nakagawa K.; Kang J.H.; Kim J.-H.; Wang X.; Enatsu S.; Puri T.; Orlando M.; Yang J.C.-H.; Cheng Y.; PAN-CHYR YANG et al. |
| 國家衛生研究院 |
2012-05-20 |
Randomized phase II trial of TACE plus everolimus as first-line therapy in localized unresectable hepatocellular carcinoma (HCC): The TRACER trial
|
Poon, RTP;Chen, LT;Xue, HL;Tannir, B;Wang, JH;Tanwandee, T;Paik, SW |
| 國立成功大學 |
2007 |
Randomized phase II trial of thalidomide alone versus thalidomide plus interferon alpha in patients with refractory multiple myeloma
|
Chiou, Tzeon-Jye; Wang, Teng-Hsu; Chao, Tsu-Yi; Lin, Sheng-Fung; Tang, Jih-Luh; Chen, Tsai-Yun; Chang, Ming-Chih; Hsueh, Erh-Jung; Chen, Po-Min |
| 國立臺灣大學 |
2007 |
Randomized Phase Ii Trial of Thalidomide Alone Versus Thalidomide Plus Interferon Alpha in Patients with Refractory Multiple Myeloma
|
邱宗傑; 趙祖怡; 林勝豐; 唐季祿; 陳彩雲; 張明志; 薛爾榮; 陳博明; CHIOU, TZEON-JYE; CHAO, TSU-YI; LIN, SHENG-FONG; TANG, JIH-LUH; CHEN, TSAI-YUN; CHANG, MING-CHIH; HSUEH, ERH-JUNG; CHEN, PO-MIN |
| 臺大學術典藏 |
2021-01-06T03:58:49Z |
Randomized phase II trial of thalidomide alone versus thalidomide plus interferon alpha in patients with refractory multiple myeloma
|
Chiou T.-J.; Wang T.-H.; Chao T.-Y.; Lin S.-F.; JIH-LUH TANG; Chen T.-Y.; Chang M.-C.; Hsueh E.-J.; Chen P.-M. |
| 臺大學術典藏 |
2021-02-19T06:52:26Z |
Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer
|
Kojima T.;Shah M.A.;Muro K.;Francois E.;Adenis A.;Chih-Hung Hsu;Doi T.;Moriwaki T.;Kim S.-B.;Lee S.-H.;Bennouna J.;Kato K.;Shen L.;Enzinger P.;Qin S.-K.;Ferreira P.;Chen J.;Girotto G.;De La Fouchardiere C.;Senellart H.;Al-Rajabi R.;Lordick F.;Wang R.;Suryawanshi S.;Bhagia P.;Peter Kang S.;Metges J.-P.;Keynote-181 Investigators; Kojima T.; Shah M.A.; Muro K.; Francois E.; Adenis A.; CHIH-HUNG HSU; Doi T.; Moriwaki T.; Kim S.-B.; Lee S.-H.; Bennouna J.; Kato K.; Shen L.; Enzinger P.; Qin S.-K.; Ferreira P.; Chen J.; Girotto G.; de la Fouchardiere C.; Senellart H.; Al-Rajabi R.; Lordick F.; Wang R.; Suryawanshi S.; Bhagia P.; Peter Kang S.; Metges J.-P.; KEYNOTE-181 Investigators |
| 臺大學術典藏 |
2021-01-12T12:53:45Z |
Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma
|
Spicka I.; Ocio E.M.; Oakervee H.E.; Greil R.; Banh R.H.; SHANG-YI HUANG; D?�Rozario J.M.; Dimopoulos M.A.; Martínez S.; Extremera S.; Kahatt C.; Alfaro V.; Carella A.M.; Meuleman N.; Hájek R.; Symeonidis A.; Min C.-K.; Cannell P.; Ludwig H.; Sonneveld P.; Mateos M.V. |
| 國立臺灣大學 |
2005 |
Randomized Phase Iii Study of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma with Curative Resection - the Taiwan Cooperative Oncology Group (Tcog T1297) Study
|
李伯皇; 鄭隆賓; 陳培哲; LEE, PO-HUANG; JENG, LONG-BIN; CHEN, PEI- JER |
| 國立臺灣大學 |
2005-10 |
Randomized phase III study of adjuvant interferon alfa-2B in hepatocellular carcinoma with curative resection - The Taiwan cooperative oncology group (TCOG T1297) study
|
Chen, LT; Chen, MF; Lee, LA; Lee, PH; Jeng, LB; Lin, DY; Wu, CC; Mok, KT; Chen, CL; Lee, WC; Chau, GY; Chen, YS; Lui, WY; Chen, PJ |
| 國立成功大學 |
2018 |
Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer
|
Gerber, D.E.;Horn, L.;Boyer, M.;Sanborn, R.;Natale, R.;Palmero, R.;Bidoli, P.;Bondarenko, I.;Germonpre, P.;Ghizdavescu, D.;Kotsakis, A.;Lena, H.;Losonczy, G.;Park, K.;Su, W.-C.;Tang, M.;Lai, J.;Kallinteris, N.L.;Shan, J.S.;Reck, M.;Spigel, D.R. |
Showing items 707601-707625 of 2347236 (93890 Page(s) Totally)
<< < 28300 28301 28302 28303 28304 28305 28306 28307 28308 28309 > >>
View [10|25|50] records per page
|
